Efficacy of high-dose intravenous immunoglobulins in two patients with idiopathic recurrent pericarditis refractory to previous immunosuppressive treatment

Italian Heart Journal

Volumn 4, Issue 1, 2003, Pages 64-68

  Tona, Franceso ^b   Bellotto, Fabio ^b   Laveder, Francesco ^a   Meneghin, Alessia ^b   Sinagra, Gianfranco ^c   Marcolongo, Renzo ^b  

^a Civic Hospital   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^c Department of Transfusion Medicine   (Italy)

Author keywords

Autoimmunity; Pericarditis

Indexed keywords

ANTIBIOTIC AGENT; ANTIPYRETIC AGENT; AZATHIOPRINE; COLCHICINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IG VENAN N; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INDOMETACIN; METHOTREXATE; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; STEROID;

ADULT; ARTICLE; CASE REPORT; DRUG EFFECT; DRUG EFFICACY; DRUG INFUSION; DRUG MECHANISM; DRUG MEGADOSE; DRUG RESISTANCE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HUMAN; IDIOPATHIC DISEASE; IMMUNOREACTIVITY; IMMUNOSUPPRESSIVE TREATMENT; MALE; PATHOGENESIS; PERICARDIAL EFFUSION; PERICARDITIS; RECURRENT DISEASE; THORAX PAIN;

ADULT; COLCHICINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; MALE; PERICARDITIS; PREDNISONE; RECURRENCE; TREATMENT OUTCOME;

EID: 0038287860     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Shabetai R. Acute pericarditis. Cardiol Clin 1990; 4: 639-44.
2. Spodick DH. Diseases of the pericardium. In: Parmley WW, Chatterjee K, eds. Cardiology. Philadelphia, PA: JB Lippincott, 1992: 1-34.
3. Fowler NO. Recurrent pericarditis. Cardiol Clin 1990; 4: 621-6.
4. Houghton JL. Pericarditis and myocarditis. Which is benign and which isn't? Postgrad Med 1992; 91: 273-82.
5. Pankuweit S, Wadlich A, Meyer E, et al. Cytokine activation in pericardial fluids in different forms of pericarditis. Herz 2000; 25: 748-54.
6. Kazatchkinine MK, Kaveri SV. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 2001; 345: 747-55.
7. Yu Z, Lennon VA. Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases. N Engl J Med 1999; 340: 227-8.
8. Travaglio-Encinoza A, Anaya JM, Dupuy Diangeac AD, et al. Rheumatoid pericarditis: new immunopathological aspects. Clin Exp Rheumatol 1994; 12: 313-6.
9. Bird AG, Mustchin CP. Immunological studies in a case of idiopathic relapsing pericarditis. Eur Heart J 1987; 8 (Suppl J): 199-201.
10. Guindo J, Rodriguez de la Serna A, Rarnio J, et al. Recurrent pericarditis. Relief with colchicine. Circulation 1990; 82: 1117-20.
11. Millaire A, de Groote P, Decoulx X, et al. Treatment of recurrent pericarditis with colchicine. Eur Heart J 1994; 15: 120-4.
12. Adler Y, Finkelstein Y, Guindo J, et al. Colchicine treatment for recurrent pericarditis. Circulation 1998; 97: 2183-5.
13. Melchior TM, Ringsdal V, Hildebrandt P, et al. Recurrent acute idiopathic pericarditis treated with intravenous methylprednisolone given as pulse therapy. Am Heart J 1992; 123: 1086-8.
14. Asplen CH, Levine HD. Azathioprine therapy of steroid responsive pericarditis. Am Heart J 1970; 80: 109-11.
15. Marcolongo R, Russo R, Laveder F, et al. Immunosuppressive therapy prevents recurrent pericarditis. J Am Coll Cardiol 1995; 26: 1276-9.
16. Lessio S, Tona F, Rigoli A, et al. Cyclosporin A in the treatment of idiopathic recurrent pericarditis: a case report. J Clin Basic Cardiol 1999; 2: 130-1.
17. Hjortkjoer-Petersen H, Nielsen H, Hansen M, et al. High-dose immunoglobulin therapy in pericarditis caused by SLE. (letter) Scand J Rheumatol 1990; 19: 91-3.
18. Dwyer JM. Manipulating the immune system with immunoglobulins. N Engl J Med 1992; 326: 107-16.
19. Berchtold P, McMillan R. Intravenous immunoglobulin: new aspects of mechanism of action in chronic ITP. In: Imbach P, ed. Immunotherapy with intravenous immunoglobulins. London: Academic Press, 1991: 245-52.
20. Bussel JB. Treatment effects on chronic idiopathic thrombocytopenia purpura. In: Imbach P, ed. Immunotherapy with intravenous immunoglobulins. London: Academic Press, 1991: 253-9.
21. Furusho K, Kamiya T, Nakano H, et al. High dose intravenous gammaglobulin for Kawasaki disease. Lancet 1984; 2: 1055-8.
22. Newburger JW, Takahashi M, Burns JC, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 1986; 315: 341-7.
23. Tomino Y, Sakai H, Takaya M, et al. Solubilization of intraglomerular deposits of IgG immune complexes by human sera or gammaglobulin in patients with lupus nephritis. Clin Exp Immunol 1984; 58: 42-8.
24. Mouthon L, Lacroix-Desmazes S, Pashov A, Kaveri SV, Kazatchkine MD. Immunomodulatory effects of intravenous immunoglobulins in autoimmune diseases. Rev Med Interne 1999; 20 (Suppl 4): 423S-430S.
25. Ballow M. Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory diseases. J Allergy Clin Immunol 1997; 100: 151-7.